The life sciences BPO market comprises medical billing, medical coding, clinical documentation and other financial services that are outsourced by pharmaceutical, biotechnology and medical device companies. These services help life sciences companies to optimize operational costs and enhance business processes. The life sciences BPO sector relies on skilled professionals to handle complex billing, coding and clinical documents in compliance with global regulations. With increasing R&D expenditure and patent expires, pharmaceutical companies are outsourcing non-core operational services to focus on drug development.
The Global life sciences BPO market is estimated to be valued at USD 408.1 Bn in 2024 and is expected to reach USD 972.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.
Key Takeaways
Key players operating in the life sciences BPO market are Accenture, Plc, Boehringer Ingelheim GmbH, Cognizant. Accenture is one of the leading provider of medical billing and coding services while Cognizant offers data management services to top 10 pharmaceutical companies.
The key opportunities in the market include increasing adoption of AI-based technologies by BPO players. AI can help in automating repetitive tasks related to clinical documentation and claims management. This will help life sciences companies and BPO players to improve operational efficiency.
Life Sciences Bpo Market size is witnessing strong global expansion especially in emerging markets of Asia Pacific and Latin America. Countries like India, Philippines and Costa Rica are attracting investments by multinational BPO companies due to availability of skilled workforce and tax incentives. This will help life sciences companies to achieve significant cost savings.
Market drivers
Strong outsourcing trends: Driven by need to cut operational costs and focus on core activities, pharmaceutical companies are increasingly outsourcing non-core functions like billing, coding and data management to third-party BPO providers. This is a key growth driver.
Adoption of new technologies: BPO players are leveraging AI, RPA, cloud computing etc to automate routine tasks and offer transformational services to clients. Life sciences companies are also adopting new technologies through BPO which is propelling market growth.
Market restraints
Data privacy laws: Concerns around patient data privacy and stringent regulations in some countries can limit scope of services that can be outsourced. This poses a challenge for BPO vendors targeting markets with strict privacy laws.
Reliability issues: Outsourcing clinical or financial services requires high reliability from business process outsourcing firms. Any non-compliance or error can severely impact life sciences companies. This makes some companies reluctant to outsource critical functions.
Segment Analysis
The life sciences BPO market can be segmented based on pharmaceutical services and medical device services. Pharmaceutical services currently dominate the market and are expected to continue their dominance over the forecast period. Various drug discovery and clinical trial processes are being outsourced to specialized BPO companies by big pharmaceutical firms, driving the growth of the pharmaceutical services segment. Preclinical, clinical trial management, clinical data management are some of the key pharmaceutical services seeing high outsourcing. Medical device services segment is also gaining traction as companies look to outsource activities like regulatory affairs services, product testing and certification services to focus on their core competencies.
Global Analysis
North America currently holds the largest share in the life sciences BPO market and is expected to remain the dominant region during the forecast period. High healthcare expenditure, presence of many global pharmaceutical players and medical technology companies are some factors driving outsourcing activities in the region. Asia Pacific region is anticipated to grow at the fastest pace owing to rising diseases burden, increasing R&D investments and improving healthcare infrastructure in countries like India, China and Japan. India has emerged as a key destination for pharmaceutical and medical device outsourcing due to availability of low cost and high skilled workforce. Availability of special economic zones and government initiatives are also attracting companies to set up facilities in the region.
Get More Insights On Life Sciences Bpo Market
Get this Report in Japanese Language
Get this Reports in Korean Language
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191 )
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript">